These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25657110)

  • 1. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.
    Cao Y; Liu X; Lu W; Chen Y; Wu X; Li M; Wang XA; Zhang F; Jiang L; Zhang Y; Hu Y; Xiang S; Shu Y; Bao R; Li H; Wu W; Weng H; Yen Y; Liu Y
    Cancer Lett; 2015 May; 360(2):141-50. PubMed ID: 25657110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
    Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
    J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer.
    Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X
    Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SNORA74B gene silencing inhibits gallbladder cancer cells by inducing PHLPP and suppressing Akt/mTOR signaling.
    Qin Y; Meng L; Fu Y; Quan Z; Ma M; Weng M; Zhang Z; Gao C; Shi X; Han K
    Oncotarget; 2017 Mar; 8(12):19980-19996. PubMed ID: 28212545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
    Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
    J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
    Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
    Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition.
    Zong H; Yin B; Zhou H; Cai D; Ma B; Xiang Y
    Mol Biol Rep; 2014 Jul; 41(7):4507-12. PubMed ID: 24623408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors.
    Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo.
    Jung J; Son YS; Park H; Jeon SK; Lee JW; Choi SY; Kim JM; Kwon YG; Hong HJ; Min JK
    Oncol Rep; 2011 Apr; 25(4):945-52. PubMed ID: 21318226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent therapeutics for gallbladder cancer by combinatorial inhibition of the MAPK and mTOR signaling networks.
    Mohri D; Ijichi H; Miyabayashi K; Takahashi R; Kudo Y; Sasaki T; Asaoka Y; Tanaka Y; Ikenoue T; Tateishi K; Tada M; Isayama H; Koike K
    J Gastroenterol; 2016 Jul; 51(7):711-21. PubMed ID: 26614007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
    BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of hypoxia-induced fibronectin-integrin β1 expression in embryonic stem cell proliferation and migration: Involvement of PI3K/Akt and FAK.
    Lee SH; Lee YJ; Han HJ
    J Cell Physiol; 2011 Feb; 226(2):484-93. PubMed ID: 20677223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin inhibits proliferation, migration, and invasion by inducing ROS-mediated apoptosis via suppression of the PI3K/Akt/mTOR signaling pathway in gallbladder cancer cells.
    Chen K; Zhu P; Chen W; Luo K; Shi XJ; Zhai W
    Aging (Albany NY); 2021 Sep; 13(18):22502-22515. PubMed ID: 34580235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase II alpha promotes gallbladder cancer proliferation and metastasis through activating phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway.
    Lyu WJ; Shu YJ; Liu YB; Dong P
    Chin Med J (Engl); 2020 Oct; 133(19):2321-2329. PubMed ID: 32925281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.